Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
676.00    -9.00 (-1.31%)
Bid:
744.00
Ask:
617.00
Spread: -127.00 (-17.07%)
Market Cap: £656.54m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Trading Update

19 Apr 2011 07:00

RNS Number : 1357F
Acal PLC
19 April 2011
 



For Release

7.00am, 19 April 2011

 

 

Acal plc

Fourth Quarter Trading Update

Continuing strong growth with Group like for like sales1 up 17%

 

Acal plc (LSE : ACL, "The Group"), the European specialist provider of technology products and services, is today issuing a trading update for its year ended 31 March 2011, ahead of the announcement of its preliminary results on 1 June 2011.

 

The Board is pleased to report that, since its second interim management statement on 3 February 2011, trading has continued to remain strong. In the fourth quarter ended 31 March 2011, Group like for like sales1 increased by 17% year on year.

 

Group sales continue to be driven by a strong Electronics order book. The Electronics division (which accounts for approximately 78% of Group sales) reported a fourth quarter increase in like for like sales1 of 21% despite more challenging comparators.

 

Sales of products manufactured in Japan (all of which are in the Electronics division and represent approximately 4% of Group revenues), were not significantly impacted by the earthquake in mid March and Acal has continued to meet its customers' needs. 

 

The acquisition of Compotron GmbH ("Compotron"), a specialist provider of electronic communication components, was completed with effect from 1 January 2011. Since the acquisition, Compotron has performed well and ahead of our expectations.

 

In the non-Electronics businesses (approximately 22% of Group sales), total like for like sales1 in the fourth quarter were up 7%.

 

As a result, we expect full year results for this year to be ahead of our previous expectations.

 

Nick Jefferies, Group Chief Executive commented:

 

"We continue to see good trading conditions in the Electronics Division across Europe. With its strong order book, Electronics like for like sales1 increased by 21% in the last quarter.

 

Overall, Group sales increased by 17%, with the non-Electronics businesses showing improved performance despite continued softness in our UK Medical business.

 

The Board remains confident that our strategy for growth both organically and by further targeted acquisitions will continue to build long term value for shareholders."

For further information please contact:

Acal plc

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

 

Cubitt Consulting

Chris Lane / Alice Coubrough

01483 544500

 

 

 

020 7367 5100

 

 

 

Notes to the Trading Update

1. Like for like sales are at constant exchange rates, including acquisitions for the whole of the comparative period and excluding the ATM Parts business (effective disposal date 30 September 2010) and a material non-core Supply Chain contract terminated at the end of the last financial year. Compotron, which was acquired in the fourth quarter, has not been included in like for like sales.

 

 Notes to Editors:

 

About Acal plc

The Acal Group is a leading technology-based specialist distributor in Europe providing sales, marketing and other services through three divisions: Electronics, Supply Chain and Medical. The Electronics Division distributes electronic and photonic products to industrial manufacturing and design companies. The Supply Chain Division provides inventory optimisation and outsource solutions to leading technology service providers while the Medical Division supplies advanced medical equipment to public and private healthcare providers. Acal has operating companies in the UK, Netherlands, Belgium, Germany, France, Italy, South Africa, Spain and the Nordic region.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDKFDQABKDOQD
Date   Source Headline
10th May 20215:33 pmRNSHolding(s) in Company
20th Apr 20217:00 amRNSFull Year Trading Update
22nd Feb 20215:26 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSAcquisition completion - Limitor GmbH
9th Feb 202112:08 pmRNSHolding(s) in Company
9th Feb 20217:00 amRNSTrading Update
27th Jan 20217:52 amRNSHolding(s) in Company
10th Dec 20208:53 amEQSdiscoverIE Group (DSCV): Another brick in the yellow wall
7th Dec 20204:42 pmRNSHolding(s) in Company
4th Dec 20207:00 amRNSAcquisition of Limitor GmbH
30th Nov 20207:00 amRNSHalf-Year Report
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
23rd Oct 20209:42 amRNSHolding(s) in Company
16th Oct 20201:23 pmRNSHolding(s) in Company
15th Oct 20205:01 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
12th Oct 20209:13 amRNSNOTIFICATION OF MAJOR HOLDINGS
8th Oct 20207:00 amRNSNotice of Trading Update & Half Year Results
26th Aug 20204:03 pmRNSHolding(s) in Company
19th Aug 202012:00 pmRNSResult of AGM
30th Jul 20207:00 amRNSTrading Update
28th Jul 20205:45 pmRNSDirector Declarations
28th Jul 20204:00 pmRNSHolding(s) in Company
27th Jul 202010:00 amRNSHolding(s) in Company
15th Jul 202011:00 amRNSAnnual Report and AGM Notice
14th Jul 202010:00 amRNSHolding(s) in Company
13th Jul 20204:15 pmRNSHolding(s) in Company
13th Jul 20204:00 pmRNSHolding(s) in Company
7th Jul 20209:00 amRNSHolding(s) in Company
3rd Jul 20209:00 amRNSHolding(s) in Company
1st Jul 20205:45 pmRNSDirector LTIP Award
30th Jun 20206:00 pmRNSHolding(s) in Company
30th Jun 20208:00 amRNSHolding(s) in Company
24th Jun 20207:00 amRNSFinal Results
3rd Jun 20201:24 pmRNSHolding(s) in Company
15th May 20207:00 amRNSYear-end & Covid-19 Trading Update
14th May 20204:05 pmRNSDirector Declaration
21st Apr 20201:00 pmRNSDirector Declaration
14th Apr 202010:19 amRNSHolding(s) in Company
9th Apr 202012:35 pmRNSHolding(s) in Company
7th Apr 20201:45 pmRNSIssue of Equity & Total Voting Rights
20th Mar 20204:42 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSYear End Trading Update
11th Mar 20203:04 pmRNSHolding(s) in Company
11th Mar 20201:49 pmRNSDirector/PDMR transaction notification
19th Feb 20207:03 amRNSDirector Declaration
30th Jan 20207:00 amRNSThird Quarter Trading Update
23rd Jan 20208:59 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.